TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 56 filers reported holding TREVI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,444 | +62.6% | 1,580 | +78.3% | 0.00% | – |
| Q2 2023 | $2,118 | -99.9% | 886 | -99.9% | 0.00% | – |
| Q3 2022 | $2,403,000 | +926.9% | 1,560,125 | +1774.6% | 0.00% | – |
| Q2 2022 | $234,000 | -85.1% | 83,225 | -85.6% | 0.00% | – |
| Q1 2021 | $1,574,000 | +12.8% | 576,500 | 0.0% | 0.00% | – |
| Q4 2020 | $1,395,000 | -56.3% | 576,500 | -27.3% | 0.00% | – |
| Q3 2020 | $3,195,000 | -38.7% | 792,700 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $5,216,000 | +100.0% | 792,700 | 0.0% | 0.00% | – |
| Q1 2020 | $2,608,000 | -12.3% | 792,700 | 0.0% | 0.00% | – |
| Q4 2019 | $2,973,000 | -16.7% | 792,700 | 0.0% | 0.00% | – |
| Q3 2019 | $3,567,000 | -40.0% | 792,700 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $5,945,000 | – | 792,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 11,370,376 | $24,787,420 | 1.91% |
| Fairmount Funds Management LLC | 5,163,287 | $11,255,966 | 1.35% |
| Opaleye Management Inc. | 1,705,900 | $3,718,862 | 1.21% |
| Frazier Life Sciences Management, L.P. | 6,881,090 | $15,000,776 | 1.00% |
| VR Adviser, LLC | 3,422,397 | $7,460,825 | 0.78% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 927,415 | $2,021,765 | 0.61% |
| Rubric Capital Management LP | 5,684,420 | $12,392,036 | 0.46% |
| Tejara Capital Ltd | 180,227 | $392,895 | 0.22% |
| PFS Partners, LLC | 100,000 | $218,000 | 0.19% |
| WealthTrust Axiom LLC | 93,500 | $203,830 | 0.07% |